Skip to main content
Journal cover image

Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial.

Publication ,  Journal Article
Foldyna, B; Udelson, JE; Karády, J; Banerji, D; Lu, MT; Mayrhofer, T; Bittner, DO; Meyersohn, NM; Emami, H; Genders, TSS; Fordyce, CB ...
Published in: Eur Heart J Cardiovasc Imaging
May 1, 2019

AIMS: To update pretest probabilities (PTP) for obstructive coronary artery disease (CAD ≥ 50%) across age, sex, and clinical symptom strata, using coronary computed tomography angiography (CTA) in a large contemporary population of patients with stable chest pain referred to non-invasive testing. METHODS AND RESULTS: We included patients enrolled in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial and randomized to CTA. Exclusively level III-certified readers, blinded to demographic and clinical data, assessed the prevalence of CAD ≥ 50% in a central core lab. After comparing the recent European Society of Cardiology-Diamond and Forrester PTP (ESC-DF) with the actual observed prevalence of CAD ≥ 50%, we created a new PTP set by replacing the ESC-DF PTP with the observed prevalence of CAD ≥ 50% across strata of age, sex, and type of angina. In 4415 patients (48.3% men; 60.5 ± 8.2 years; 78% atypical angina; 11% typical angina; 11% non-anginal chest pain), the observed prevalence of CAD ≥ 50% was 13.9%, only one-third of the average ESC-DF PTP (40.6; P < 0.001 for difference). The PTP in the new set ranged 2-48% and were consistently lower than the ESC-DF PTP across all age, sex, and angina type categories. Initially, 4284/4415 (97%) patients were classified as intermediate-probability by the ESC-DF (PTP 15-85%); using the PROMISE-PTP, 50.2% of these patients were reclassified to the low PTP category (PTP < 15%). CONCLUSION: The ESC-DF PTP overestimate vastly the actual prevalence of CAD ≥ 50%. A new set of PTP, derived from results of non-invasive testing, may substantially reduce the need for non-invasive tests in stable chest pain.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Heart J Cardiovasc Imaging

DOI

EISSN

2047-2412

Publication Date

May 1, 2019

Volume

20

Issue

5

Start / End Page

574 / 581

Location

England

Related Subject Headings

  • Prospective Studies
  • Prevalence
  • North America
  • Middle Aged
  • Male
  • Humans
  • Female
  • Coronary Artery Disease
  • Coronary Angiography
  • Computed Tomography Angiography
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Foldyna, B., Udelson, J. E., Karády, J., Banerji, D., Lu, M. T., Mayrhofer, T., … Hoffmann, U. (2019). Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging, 20(5), 574–581. https://doi.org/10.1093/ehjci/jey182
Foldyna, Borek, James E. Udelson, Júlia Karády, Dahlia Banerji, Michael T. Lu, Thomas Mayrhofer, Daniel O. Bittner, et al. “Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial.Eur Heart J Cardiovasc Imaging 20, no. 5 (May 1, 2019): 574–81. https://doi.org/10.1093/ehjci/jey182.
Foldyna, Borek, et al. “Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial.Eur Heart J Cardiovasc Imaging, vol. 20, no. 5, May 2019, pp. 574–81. Pubmed, doi:10.1093/ehjci/jey182.
Foldyna B, Udelson JE, Karády J, Banerji D, Lu MT, Mayrhofer T, Bittner DO, Meyersohn NM, Emami H, Genders TSS, Fordyce CB, Ferencik M, Douglas PS, Hoffmann U. Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):574–581.
Journal cover image

Published In

Eur Heart J Cardiovasc Imaging

DOI

EISSN

2047-2412

Publication Date

May 1, 2019

Volume

20

Issue

5

Start / End Page

574 / 581

Location

England

Related Subject Headings

  • Prospective Studies
  • Prevalence
  • North America
  • Middle Aged
  • Male
  • Humans
  • Female
  • Coronary Artery Disease
  • Coronary Angiography
  • Computed Tomography Angiography